Internship

Co-Op – CNS Biology & Microglia Differentiation

Posted on 4/18/2024

BlueRock Therapeutics

BlueRock Therapeutics

201-500 employees

Clinical stage cell therapy company

Biotechnology

New York, NY, USA

Requirements
  • Currently enrolled in a degree program at an accredited college or university biomedical, biology, or related field of study.
  • Commitment of 6-month, full-time.
  • Must be 18 years of age by the start of the internship/co-op.
  • Must have transportation to the site in New York City.
  • This position is intended to be on-site.
  • Experiences in molecular biology (quantitative PCR, immunoassays, flow cytometry) is preferred.
Responsibilities
  • Cultivate, maintain, and cryopreserve pluripotent stem cells and differentiate myeloid cells to support pipeline development.
  • Gain solid understanding of stem cell biology, scientific drivers for bioprocess development, and concepts of cell and gene therapies.
  • Perform phenotypic characterization of cell products and leverage analytical metrices to determine the reproducibility and robustness of bioprocess modifications.
  • Document experimental data in electronic laboratory notebooks in a timely and accurate manner in accordance with the company quality management standards.
  • Be a compliance champion and adhere to laboratory safety standards and follow standard operating procedures.
  • Analyze and present scientific data to colleagues in group meetings, functional meetings, and other internal meetings if applicable.

BlueRock Therapeutics is a clinical stage cell therapy company focused on harnessing the power of cell therapy to replace damaged or lost cells in order to create medicines for neurology, cardiology, and immunology indications. Their cell+gene platform utilizes cell differentiation technology to produce authentic cell therapies, with the potential to restore or regenerate lost function.

Company Stage

M&A

Total Funding

$807M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

2%

1 year growth

2%

2 year growth

51%
INACTIVE